SCHEMBL8700448

SCHEMBL8700448

COC(=O)c1cc2cc(CC(C)NCC(O)c3cccc(Cl)c3)ccc2n1Cc1ccc(S(C)(=O)=O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.59
ADRB2 P07550 10/20 0.52
ADRB3 P13945 11/20 0.51
ADRB1 P08588 7/20 0.51
GLA P06280 1/20 0.51
CYP2D6 P10635 2/20 0.50
CYP3A4 P08684 1/20 0.50
HIF1A Q16665 1/20 0.50
SLC2A1 P11166 2/20 0.49
ADRA1D P25100 2/20 0.49
ADRA1A P35348 2/20 0.49
ADRA1B P35368 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
ALOX15 P16050 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
TSHR P16473 1/20 0.48
NFKB1 P19838 1/20 0.48
ADRA2A P08913 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8700456 1.00 PTGS2 (0.59) PTGS2ADRB2ADRB3ADRB1GLA
SCHEMBL8700452 1.00 PTGS2 (0.59) PTGS2ADRB2ADRB3ADRB1GLA
SCHEMBL8697010 0.92 ADRB3 (0.55) ADRB2ADRB3ADRB1GLACYP2D6
SCHEMBL8700159 0.92 ADRB3 (0.55) ADRB2ADRB3ADRB1GLACYP2D6
SCHEMBL8700162 0.92 ADRB3 (0.55) ADRB2ADRB3ADRB1GLACYP2D6
SCHEMBL8697542 0.91 ADRB2 (0.60) ADRB2ADRB3ADRB1GLACYP2D6
SCHEMBL8697543 0.91 ADRB2 (0.60) ADRB2ADRB3ADRB1GLACYP2D6
SCHEMBL8697547 0.91 ADRB2 (0.60) ADRB2ADRB3ADRB1GLACYP2D6
SCHEMBL8697869 0.89 ADRB2 (0.53) ADRB2ADRB3ADRB1GLACYP2D6
SCHEMBL8697556 0.89 ADRB2 (0.53) ADRB2ADRB3ADRB1GLACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5767133-A Secondary amines as antidiabetic and antiobesity agents PFIZER INC. (US) 1998-06-16 US disclosed
EP-0703911-B1 SECONDARY AMINES AS ANTIDIABETIC AND ANTIOBESITY AGENTS PFIZER (US) 1997-07-02 EP disclosed